Athens Medical C.S.A. (ATH:IATR)
Greece · Delayed Price · Currency is EUR 1.590
+0.010 (0.63%)
Sep 2, 2026, 5:08 PM EET
Athens Medical C.S.A. Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.67 | 1.78 | 8.08 | 6.85 | 15.05 |
Depreciation & Amortization | 17.45 | 16.19 | 14.38 | 13.27 | 12.43 |
Other Amortization | 2.01 | 0.62 | 0.55 | 0.51 | 0.47 |
Loss (Gain) From Sale of Assets | -0 | -0.05 | 0.05 | -0.08 | 1.36 |
Loss (Gain) on Equity Investments | 0.03 | - | - | - | - |
Other Operating Activities | 6.53 | 7.65 | 11.06 | 10.76 | 3.71 |
Change in Accounts Receivable | -18.05 | -4.83 | -40.04 | -26.18 | -3.07 |
Change in Inventory | -0.62 | -0.27 | 0.06 | -0 | -0.11 |
Change in Other Net Operating Assets | 2.41 | 25.35 | 32 | -5 | -15.49 |
Operating Cash Flow | 5.09 | 46.45 | 26.13 | 0.12 | 15.75 |
Operating Cash Flow Growth | -89.05% | 77.76% | 20971.77% | -99.21% | -60.83% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -16.92 | -26.63 | -22.35 | -15.87 | -11.28 |
Sale of Property, Plant & Equipment | 0.01 | 0.02 | 0.02 | 0.05 | 0.44 |
Investment in Securities | -0.91 | -0.5 | -1.31 | - | - |
Other Investing Activities | 0.12 | 0.02 | 0.03 | 0.04 | 3.9 |
Investing Cash Flow | -17.7 | -27.1 | -23.61 | -15.78 | -6.95 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 54.64 | 5.42 | 30.06 | 10.19 | 9.5 |
Total Debt Issued | 54.64 | 5.42 | 30.06 | 10.19 | 9.5 |
Long-Term Debt Repaid | -28.14 | -27.47 | -24.65 | -23.79 | -15.49 |
Total Debt Repaid | -28.14 | -27.47 | -24.65 | -23.79 | -15.49 |
Net Debt Issued (Repaid) | 26.5 | -22.05 | 5.41 | -13.6 | -5.99 |
Repurchase of Common Stock | - | - | -2.59 | -6.04 | - |
Common Dividends Paid | - | -1.73 | - | - | -0.08 |
Other Financing Activities | -0.1 | -0.03 | -0.06 | 0 | - |
Financing Cash Flow | 26.4 | -23.8 | 2.76 | -19.65 | -6.07 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 13.79 | -4.45 | 5.28 | -35.3 | 2.73 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.83 | 19.82 | 3.78 | -15.75 | 4.47 |
Free Cash Flow Growth | - | 424.42% | - | - | -86.52% |
Free Cash Flow Margin | -4.29% | 7.34% | 1.46% | -6.75% | 1.98% |
Free Cash Flow Per Share | -0.14 | 0.23 | 0.04 | -0.18 | 0.05 |
Levered Free Cash Flow | -0.2 | 17.8 | -10.08 | -18.32 | 8.36 |
Unlevered Free Cash Flow | 6.9 | 24.49 | -4.25 | -13.55 | 12.46 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 9.69 | 10.29 | 8.55 | 3.5 | 5.97 |
Cash Income Tax Paid | 1.72 | 1.74 | 1.49 | 1.17 | 1.11 |
Change in Working Capital | -16.26 | 20.26 | -7.99 | -31.18 | -18.68 |